Impetigo
☆ AI Dermatology — Free Service
Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Kawża ta’ impetigo fuq il-ġadam. L‑impetigo għandu jkun sospettat f’tifel żgħir li m’għandux storja ta’ korriment, iżda li għandu feriti li qed jinfirxu.
B'differenza mid-dermatite atopika, l-impetigo jeħtieġ trattament antibijotiku u jista' jikkawża tixrid bl-użu ta' sterojdi.
relevance score : -100.0%
ReferencesImpetigo, l-aktar infezzjoni batterika komuni tal-ġilda f’tfal bejn sentejn u ħames snin, jseħħ f’żewġ tipi ewlenin: mhux bullous (70 % tal-każijiet) u bullous (30 % tal-każijiet). Impetigo mhux bullous huwa tipikament ikkawżat minn Staphylococcus aureus jew Streptococcus pyogenes. Huwa rikonoxxut minn qxur kulur l‑għasel fuq il‑wiċċ u r‑riġlejn, u jimmira prinċipalment il-ġilda; jista'jinfetta gdim ta' insetti, ekżema, jew leżjonijiet erpetiċi. L‑impetigo bullous, ikkawżat biss minn Staphylococcus aureus, iwassal għal bullae kbar u flaċċidi, u spiss jaffettwa żoni fejn il-ġilda togħrok flimkien. Iż-żewġ tipi ġeneralment jiċċaraw fi żmien ġimagħtejn sa tliet ġimgħat mingħajr ċikatriċi, u l‑kumplikazzjonijiet huma rari; il‑glomerulonefrite poststreptokokkali hija l‑aktar severa. It‑trattament jinvolvi antibijotiċi topiċi (mupirocin, retapamulin, fusidic acid). Antibijotiċi orali jistgħu jkunu meħtieġa għal impetigo bullous kbir jew meta trattament topiku ma jkunx fattibbli. Filwaqt li bosta antibijotiċi orali (amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, macrolides) huma għażliet, il‑peniċillina mhix effettiva. Id‑diżinfettanti topiċi mhumiex tajbin bħala sostitut għall‑antibijotiċi u għandhom jiġu evitati. Fusidic acid, mupirocin, u retapamulin huma effettivi kontra Staphylococcus aureus suxxettibbli għall‑methicillin u kontra infezzjonijiet streptokokkali. Clindamycin huwa utli għal infekzjonijiet sospettati b’Staphylococcus aureus reżistenti għall‑methicillin (MRSA). Trimethoprim/sulfamethoxazole jaħdem kontra Staphylococcus aureus reżistenti għall‑methicillin, iżda mhux biżżejjed għal infezzjoni streptokokkali.
Impetigo, the most common bacterial skin infection in children aged two to five, comes in two main types: nonbullous (70% of cases) and bullous (30% of cases). Nonbullous impetigo is typically caused by Staphylococcus aureus or Streptococcus pyogenes. It's recognized by honey-colored crusts on the face and limbs and mainly targets the skin or can infect insect bites, eczema, or herpetic lesions. Bullous impetigo, caused solely by S. aureus, leads to large, flaccid bullae and often affects areas where skin rubs together. Both types usually clear up within two to three weeks without scarring, and complications are rare, with poststreptococcal glomerulonephritis being the most severe. Treatment involves topical antibiotics (mupirocin, retapamulin, fusidic acid). Oral antibiotics might be necessary for impetigo with large bullae or when topical treatment isn't feasible. While several oral antibiotics (amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, macrolides) are options, penicillin isn't effective. Topical disinfectants aren't as good as antibiotics and should be avoided. Fusidic acid, mupirocin, retapamulin are effective against methicillin-susceptible S. aureus and streptococcal infections. Clindamycin is useful for suspected methicillin-resistant S. aureus infections. Trimethoprim/sulfamethoxazole works against methicillin-resistant S. aureus, but isn't enough for streptococcal infection.
Impetigo, the most common bacterial skin infection in children aged two to five, comes in two main types: nonbullous (70% of cases) and bullous (30% of cases). Nonbullous impetigo is typically caused by Staphylococcus aureus or Streptococcus pyogenes. It's recognized by honey-colored crusts on the face and limbs and mainly targets the skin or can infect insect bites, eczema, or herpetic lesions. Bullous impetigo, caused solely by S. aureus, leads to large, flaccid bullae and often affects areas where skin rubs together. Both types usually clear up within two to three weeks without scarring, and complications are rare, with poststreptococcal glomerulonephritis being the most severe. Treatment involves topical antibiotics (mupirocin, retapamulin, fusidic acid). Oral antibiotics might be necessary for impetigo with large bullae or when topical treatment isn't feasible. While several oral antibiotics (amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, macrolides) are options, penicillin isn't effective. Topical disinfectants aren't as good as antibiotics and should be avoided. Fusidic acid, mupirocin, retapamulin are effective against methicillin-susceptible S. aureus and streptococcal infections. Clindamycin is useful for suspected methicillin-resistant S. aureus infections. Trimethoprim/sulfamethoxazole works against methicillin-resistant S. aureus, but isn't enough for streptococcal infection.
Impetigo hija infezzjoni komuni tal-ġilda kkawżata minn ċerti batterji, li tinfirex faċilment permezz tal-kuntatt. Normalment jidher bħala rqajja' ħomor miksija b'qoxra safra u tista' jikkawża ħakk jew uġigħ. Din l‑infezzjoni hija l-aktar komuni fost it-tfal li jgħixu f'żoni sħan u umdi. Jista' jidher bħala folji jew mingħajr folji. Filwaqt li ħafna drabi taffettwa l-wiċċ, tista' seħħ kullimkien fejn hemm waqfa fil-ġilda. Id-dijanjosi tiddependi prinċipalment fuq is-sintomi u kif jidher. It-trattament ġenerali jinkludi antibijotiċi, kemm topiċi kif ukoll orali, flimkien mal-ġestjoni tas-sintomi.
Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria. It most commonly presents as erythematous plaques with a yellow crust and may be itchy or painful. The lesions are highly contagious and spread easily. Impetigo is a disease of children who reside in hot humid climates. The infection may be bullous or nonbullous. The infection typically affects the face but can also occur in any other part of the body that has an abrasion, laceration, insect bite or other trauma. Diagnosis is typically based on the symptoms and clinical manifestations alone. Treatment involves topical and oral antibiotics and symptomatic care.
Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria. It most commonly presents as erythematous plaques with a yellow crust and may be itchy or painful. The lesions are highly contagious and spread easily. Impetigo is a disease of children who reside in hot humid climates. The infection may be bullous or nonbullous. The infection typically affects the face but can also occur in any other part of the body that has an abrasion, laceration, insect bite or other trauma. Diagnosis is typically based on the symptoms and clinical manifestations alone. Treatment involves topical and oral antibiotics and symptomatic care.
Impetigo huwa tipikament ikkawżat minn Staphylococcus aureus jew Streptococcus pyogenes. Bil-kuntatt jista' jinfirex bejn in-nies. Fil-każ tat-tfal, huwa kontaġjuż għall-aħwa tagħhom.
It-trattament huwa tipikament b'kremi antibijotiċi bħal mupirocin jew fusidic acid. Antibijotiċi orali, bħal cefalexin, jistgħu jintużaw jekk jiġu affettwati żoni kbar.
Impetigo affettwa madwar 140 miljun ruħ (2 % tal-popolazzjoni dinjija) fl-2010. Jista' jseħħ fi kwalunkwe età, iżda huwa l-iktar komuni f'tfal żgħar. Kumplikazzjonijiet jistgħu jinkludu ċellulite jew glomerulonefrite poststreptokokkali.
○ Trattament – Medikazzjonijiet OTC
* Minħabba li impetigo hija marda infettiva, ingwenti sterojdi m'għandhomx jintużaw. Jekk għandek problemi biex tiddistingwi leżjonijiet impetigo minn ekżema, jekk jogħġbok ħu anti‑istaminiċi OTC mingħajr ma tuża l-ingwenti sterojdi.
#OTC antihistamine
* Jekk jogħġbok applika ingwent antibijotiku OTC għall-leżjoni.
#Bacitracin
#Polysporin